Charleston Laboratories, Inc. is a pharmaceutical company based in Jupiter, Florida, focused on developing innovative treatments for acute pain and opioid-induced nausea/vomiting. The company is actively working to resubmit NDAs and reacquire rights to promising therapies like CL-108, with plans to form a U.S. commercial subsidiary to support future market access. Known for its targeted approach to solving specific pain management challenges, Charleston Laboratories stands out for its dedication to advancing niche therapeutics with reduced side effect profiles.
See how much Charleston Laboratories, Inc. could save with the Employee Benefit Program